No description
-
2013 (v1)PublicationUploaded on: April 14, 2023
-
2019 (v1)Publication
Charcot–Marie–Tooth (CMT) is the most common inherited neuropathy, yet has no available pharmacological therapy. Past pharmacotherapy trials failed to provide positive results, possibly due to a poor choice of outcome measures. We previously performed a study in which we validated the 6-minute walk test and StepWatch™ Activity Monitor in CMT....
Uploaded on: April 14, 2023 -
2023 (v1)Publication
Background and purpose: Data are reported from the Italian CMT Registry.Methods: The Italian CMT Registry is a dual registry where the patient registers and chooses a reference center where the attending clinician collects a minimal dataset of information and administers the Charcot-Marie-Tooth (CMT) Examination/Neuropathy Score. Entered data...
Uploaded on: December 25, 2023